Search Results - "VON MALLEK, Dirk"

68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer by Heinzel, Alexander, Boghos, Dima, Mottaghy, Felix M., Gaertner, Florian, Essler, Markus, von Mallek, Dirk, Ahmadzadehfar, Hojjat

“…Purpose To evaluate the use of 68 Ga-PSMA PET/CT for monitoring response to 177 Lu-617 PSMA radioligand therapy in patients with metastatic castrate-resistant…”
Get full text

Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer by Gutsche, Robin, Gülmüs, Gizem, Mottaghy, Felix M., Gärtner, Florian, Essler, Markus, von Mallek, Dirk, Ahmadzadehfar, Hojjat, Lohmann, Philipp, Heinzel, Alexander

“…Objective The treatment with 177 Lutetium PSMA ( 177 Lu-PSMA) in patients with metastatic castration-resistant prostate cancer (mCRPC) has recently been…”
Get full text

Induced urinary crystal formation as an analytical strategy for the prediction and monitoring of urolithiasis and other metabolism-related disorders by Laube, Norbert, Berg, Wolfgang, Bernsmann, Falk, Gravius, Sascha, Klein, Florian, Latz, Stefan, Mallek, Dirk von, Porowski, Tadeusz, Randau, Thomas, Wasilewska, Anna, Fisang, Christian

“…Crystal formation reflects the entire composition of the surrounding solution. In case of urolithiasis, induced crystal formation in native urine has led to…”
Get full text

Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome by REINHARDT, Michael J, BRINK, Ingo, JOE, Alexius Y, VON MALLEK, Dirk, EZZIDDIN, Samer, PALMEDO, Holger, KRAUSE, Thomas M

“…This study was performed with three aims. The first was to analyse the effectiveness of radioiodine therapy in Graves' disease patients with and without…”
Get full text

Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy? by Reinhardt, Michael J, Biermann, Kim, Wissmeyer, Michael, Juengling, Freimut D, Brockmann, Holger, von Mallek, Dirk, Ezziddin, Samer, Joe, Alexius Y, Krause, Thomas M

“…The aim of this study was to evaluate the feasibility of applying a previously described dose strategy based on (99m)Tc-pertechnetate thyroid uptake under…”
Get full text

Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head by Ooms, Mark, von Mallek, Dirk, Kaiser, Hans-Jürgen, Hölzle, Frank, Mottaghy, Felix M., Modabber, Ali

“…Purpose Sentinel lymph node (SLN) biopsy is a staging procedure in the management of cutaneous malignancies of the head. The ideal radiopharmaceutical is…”
Get full text

99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types by Altunay, Betül, Goedicke, Andreas, Winz, Oliver H., Hertel, Fabian, von Mallek, Dirk, Meszaros, Levente K., Chand, Gitasha, Biersack, Hans-Jürgen, Stickeler, Elmar, Krauss, Katja, Mottaghy, Felix M.

“…The expression status of human epidermal growth factor receptor 2 (HER2) in cancer predicts response to HER2-targeted therapy. Therefore, its accurate…”
Get full text

Prostate-specific membrane antigen radioligand therapy of prostate cancer by Beheshti, Mohsen, Heinzel, Alexander, von Mallek, Dirk, Filss, Christian, Mottaghy, Felix M

“…Defining an optimal therapeutic approach in metastatic castration-resistance prostate cancer (mCRPC) patients in advanced stages is still challenging in…”
Get full text

Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake by Reinhardt, Michael J, Joe, Alexius, von Mallek, Dirk, Zimmerlin, Martina, Manka-Waluch, Agnieszka, Palmedo, Holger, Krause, Thomas M

“…The aim of this study was to optimise radioiodine therapy of diffuse and nodular toxic goitre by calculation of the radiation dose delivered to the thyroid on…”
Get full text

Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis by Biersack, Hans-Jürgen, Palmedo, Holger, Andris, Andrej, Rogenhofer, Stefan, Knapp, Furn F, Guhlke, Stefan, Ezziddin, Samer, Bucerius, Jan, von Mallek, Dirk

“…This retrospective study compared the effects of single and multiple administrations of (186)Re-hydroxyethylidenediphosphonate ((186)Re-HEDP) on palliation and…”
Get full text

Multicentric 68 Ga-PSMA PET radiomics for treatment response assessment of 177 Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer by Gutsche, Robin, Gülmüs, Gizem, Mottaghy, Felix M, Gärtner, Florian, Essler, Markus, von Mallek, Dirk, Ahmadzadehfar, Hojjat, Lohmann, Philipp, Heinzel, Alexander

“…The treatment with Lutetium PSMA ( Lu-PSMA) in patients with metastatic castration-resistant prostate cancer (mCRPC) has recently been approved by the FDA and…”
Get full text

99m Tc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types by Altunay, Betül, Goedicke, Andreas, Winz, Oliver H, Hertel, Fabian, von Mallek, Dirk, Meszaros, Levente K, Chand, Gitasha, Biersack, Hans-Jürgen, Stickeler, Elmar, Krauss, Katja, Mottaghy, Felix M

“…The expression status of human epidermal growth factor receptor 2 (HER2) in cancer predicts response to HER2-targeted therapy. Therefore, its accurate…”
Get full text

Female Patient with Simultaneous Occurrence of Subacute Thyroiditis and Focal Autonomy by Loberg, Christina, Mallek, Dirk, Mottaghy, Felix M, Beheshti, Mohsen, Heinzel, Alexander

“…A 57-year-old female patient presented at the emergency department with fatigue, increased sweating, flushing symptoms, loss of appetite, drowsiness and severe…”
Get more information

Dosing to rash? – The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash by Steffens, Michael, Paul, Tanusree, Hichert, Vivien, Scholl, Catharina, von Mallek, Dirk, Stelzer, Christoph, Sörgel, Fritz, Reiser, Bärbel, Schumann, Christian, Rüdiger, Stefan, Boeck, Stefan, Heinemann, Volker, Kächele, Volker, Seufferlein, Thomas, Stingl, Julia

“…Abstract Aim The aim of this study was to investigate if biomarkers of individual drug metabolism, respectively, the erlotinib/O-desmethyl-erlotinib metabolic…”
Get full text

Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor by Ataeinia, Bahar, Loberg, Christina, Kravets, Hanna, Beheshti, Mohsen, von Mallek, Dirk, Mottaghy, Felix M, Heinzel, Alexander

“…We present the case of a 77 year old male patient with metastatic pancreatic neuroendocrine tumor (NET). The patient was initially treated by extensive…”
Get full text

68 Ga-PSMA PET/CT for monitoring response to 177 Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer by Heinzel, Alexander, Boghos, Dima, Mottaghy, Felix M, Gaertner, Florian, Essler, Markus, von Mallek, Dirk, Ahmadzadehfar, Hojjat

“…To evaluate the use of Ga-PSMA PET/CT for monitoring response to Lu-617 PSMA radioligand therapy in patients with metastatic castrate-resistant prostate cancer…”
Get full text

Palliation and Survival After Repeated 188 Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis by Biersack, Hans-Jürgen, Palmedo, Holger, Andris, Andrej, Rogenhofer, Stefan, Knapp, Furn F., Guhlke, Stefan, Ezziddin, Samer, Bucerius, Jan, von Mallek, Dirk

Get full text

Palliation and Survival After Repeated ^sup 188^Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis by Biersack, Hans-Jürgen, Palmedo, Holger, Andris, Andrej, Rogenhofer, Stefan, Knapp, Furn F, Guhlke, Stefan, Ezziddin, Samer, Bucerius, Jan, von Mallek, Dirk

“…This retrospective study compared the effects of single and multiple administrations of ^sup 186^Re-hydroxyetrrylidenediphosphonate (^sup 186^Re-HEDP) on…”
Get full text

Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis by Biersack, Hans-Juergen, Palmedo, Holger, Andris, Andrej, Rogenhofer, Stefan, Knapp, Furn F, Guhlke, Stefan, Ezziddin, Samer, Bucerius, Jan, von Mallek, Dirk

“…This retrospective study compared the effects of single and multiple administrations of 186Re-hydroxyethylidenediphosphonate (186Re-HEDP) on palliation and…”
Get full text

Legal requirements for the coating of coronary stents with medications by cardiologists outside clinical investigations. Information of the Federal Institute for Medications and Medical Products and the central position of the various regions for health preservation in using medications and medical products (ZLG) by von Mallek, Dirk, Tolle, I, Stephan, K, Edelhäuser, R, Heinz, B

Get full text